glp 1 receptor agonist use and risk of suicide death suicide attempt in users GLP-1 agonists: a nationwide case-time-control study Benefit-Risk Assessment of GLP-1 Receptor
Description
Some Medicare patients will be able to access GLP-1 medication for weight loss for the first time starting July 1, paying a $50 monthly copay through a new program designed to make the drugs more...
The new class of weight-loss medications are hailed as game-changing wonder drugs, but just how safe and effective are they
Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic poly-peptide (GIP, previously known as gastric inhibitory polypeptide) are key incretin
The fascinating history of the GLP-1 drugs- Ozempic, Wegovy, and Mounjaro.
Prescription compounded semaglutide tablets with personalized care from doctors
Triple agonist (GLP-1/GIP/Glucagon), under clinical investigation
